17,040 followers
Glioma has long been associated with poor outcomes due to its rapid growth and resistance to therapy. Lab-created organoids, however, hold promise for the development of new treatments. A @BioMedCentral review explains: https://t.co/lmuOyUTOoG #GBMday #can